Gerrit Meijer
We are proud that we succeeded in implementing the complete DNA test in standard of care diagnostics, together with Hartwig Medical Foundation. Moreover, the test produces vital information for a learning healthcare system in oncology. We will be able to treat future patients even more effectively.
Back to newsMore news
Whole Genome Sequencing on Cerebrospinal Fluid: No Biopsy, Yet a Report
Whole genome sequencing is typically only performed on tissue biopsies. In collaboration with Hartwig Medical Foundation, a clinical molecular biologist …
Dutch House of Representatives votes for action of the Minister for arranging (provisional) reimbursement for whole genome sequencing-based DNA testing for most urgent groups of cancer patients
On February 25 2021, the Dutch House of Representatives adopted a motion approving reimbursement on a provisional basis of a …
Nature publication: High resolution DNA-image of metastatic tumor provides new treatment insights
For the first time, Dutch researchers have created a detailed overview of the landscape of DNA-deviations in thousands of metastatic …
More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable to find these patients. That is why every patient with metastatic cancer should be genetically screened before starting treatment.